Tonix Pharmaceuticals Holding Corp.
TNXP
$13.46
$0.221.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.11M | 10.30M | 9.83M | 10.04M | 10.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.11M | 10.30M | 9.83M | 10.04M | 10.09M |
| Cost of Revenue | 6.64M | 6.77M | 6.95M | 7.05M | 7.77M |
| Gross Profit | 6.47M | 3.53M | 2.88M | 2.99M | 2.33M |
| SG&A Expenses | 87.68M | 67.59M | 49.60M | 40.90M | 40.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.81M | 110.20M | 92.22M | 82.49M | 87.84M |
| Operating Income | -125.70M | -99.90M | -82.38M | -72.45M | -77.74M |
| Income Before Tax | -124.02M | -99.22M | -81.42M | -131.93M | -130.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -124.02 | -99.22 | -81.42 | -131.93 | -130.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -124.02M | -99.22M | -81.42M | -131.93M | -130.04M |
| EBIT | -125.70M | -99.90M | -82.38M | -72.45M | -77.74M |
| EBITDA | -123.78M | -97.96M | -79.90M | -69.54M | -74.32M |
| EPS Basic | -14.26 | -20.05 | -39.15 | -1.96K | -2.49K |
| Normalized Basic EPS | -8.69 | -12.31 | -24.25 | -323.87 | -657.14 |
| EPS Diluted | -14.26 | -20.05 | -39.15 | -1.96K | -2.49K |
| Normalized Diluted EPS | -8.69 | -12.31 | -24.25 | -323.87 | -657.14 |
| Average Basic Shares Outstanding | 33.98M | 24.44M | 16.14M | 8.86M | 2.96M |
| Average Diluted Shares Outstanding | 33.98M | 24.44M | 16.14M | 8.86M | 2.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |